氧化应激在胃癌中的研究进展
Research Progress of Oxidative Stress in Gastric Cancer
DOI: 10.12677/ACM.2023.133562, PDF,   
作者: 周 璇, 李林俞, 潘旭红:甘肃中医药大学第一临床医学院,甘肃 兰州;甘肃省人民医院肿瘤内科,甘肃 兰州;李红玲*:甘肃省人民医院肿瘤内科,甘肃 兰州
关键词: 氧化应激胃癌机制预防治疗Oxidative Stress Gastric Cancer Mechanism Prevention Treatment
摘要: 胃癌(GC)是世界上癌症死亡率最高的原因之一,因其侵袭性强,生存率低,复发转移率高,严重威胁着全球44亿人类的健康。氧化应激是一种由机体内氧化过程中的基因突变、氧化分子的增加以及抗氧化剂的减少所造成的危害。氧化应激学说是胃癌发生和发展机制研究中的重要学说之一,这两者之间的关系一直备受关注。本文就这一话题结合国内外研究结果,分别介绍了氧化应激的定义、胃癌的基本概念和细胞氧化应激能够产生的各种损害。重点介绍了氧化应激的发病机制和胃癌的临床特征,并且总结了氧化应激在胃癌中的作用。通过调控氧化应激的分子机制来预防和治疗胃癌,或可能成为GC诊断及治疗研究的方向。
Abstract: Gastric cancer (GC) is one of the causes of the highest cancer mortality in the world. Due to its strong invasiveness, low survival rate and high recurrence and metastasis rate, GC poses a serious threat to the health of 4.4 billion people worldwide. Oxidative stress is a harm caused by genetic mutations in the body’s oxidation process, an increase in oxidative molecules, and a decrease in antioxidants. The theory of oxidative stress is one of the important theories in the study of the pathogenesis and development of gastric cancer, and the relationship between the two has attracted much attention. This paper introduces the definition of oxidative stress, the basic concept of gastric cancer and the damage caused by cellular oxidative stress. This paper focuses on the pathogenesis of oxidative stress and the clinical features of gastric cancer, and summarizes the role of oxidative stress in gastric cancer. The prevention and treatment of gastric cancer by regulating the molecular mechanism of oxidative stress may become the direction of GC diagnosis and treatment.
文章引用:周璇, 李林俞, 潘旭红, 李红玲. 氧化应激在胃癌中的研究进展[J]. 临床医学进展, 2023, 13(3): 3919-3925. https://doi.org/10.12677/ACM.2023.133562

参考文献

[1] Wang, L.Y., Zhao, S., Lv, G.J., et al. (2020) Mechanisms of Resveratrol in the Prevention and Treatment of Gastroin-testinal Cancer. World Journal of Clinical Cases, 8, 2425-2437. [Google Scholar] [CrossRef] [PubMed]
[2] Farkhondeh, T., Pourbagher-Shahri, A.M., Azimi-Nezhad, M., et al. (2021) Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies. Molecules, 26, 3157. [Google Scholar] [CrossRef] [PubMed]
[3] 赵雅茹, 武云. 胃癌常见生物标记物及相应靶向治疗的研究进展[J]. 实用肿瘤学杂志, 2022, 36(5): 483-488.
[4] 扈小发, 邓明飞. 胃癌多方式治疗探析[J]. 中国中医药现代远程教育, 2021, 19(8): 201-203.
[5] Hironaka, S. (2019) Anti‐Angiogenic Therapies for Gastric Cancer. Asia Journal of Clinical Oncology, 15, 208-217. [Google Scholar] [CrossRef] [PubMed]
[6] Niccolai, E., Taddei, A., Prisco, D., et al. (2015) Gastric Cancer and the Epoch of Immunotherapy Approaches. World Journal of Gastroenterology, 21, 5778-5793. [Google Scholar] [CrossRef] [PubMed]
[7] Jelic, M.D., Mandic, A.D., Maricic, S.M. and Srdjenovic, B.U. (2021) Oxidative Stress and Its Role in Cancer. Journal of Cancer Research and Therapeutics, 17, 22-28. [Google Scholar] [CrossRef
[8] Tamimi, R.M., Lagiou, P., Adami, H.O., et al. (2002) Prospects for Chemoprevention of Cancer. Journal of Internal Medicine, 251, 286-300. [Google Scholar] [CrossRef] [PubMed]
[9] Wu, Z., Wang, L., Wen, Z. and Yao, J. (2021) Integrated Analysis Identifies Oxidative Stress Genes Associated with Progression and Prognosis in Gastric Cancer. Scientific Reports, 11, Article No. 3292. [Google Scholar] [CrossRef] [PubMed]
[10] Ock, C.Y. (2012) 8-Hydroxydeoxyguanosine: Not Mere Bi-omarker for Oxidative Stress, but Remedy for Oxidative Stress-Implicated Gastrointestinal Diseases. World Journal of Gastroenterology, 18, 302. [Google Scholar] [CrossRef] [PubMed]
[11] Zhou, F., Pan, Y., Wei, Y., et al. (2017) Jab1/Csn5-Thioredoxin Sig-naling in Relapsed Acute Monocytic Leukemia under Oxidative Stress. Clinical Cancer Research, 23, 4450-4461. [Google Scholar] [CrossRef
[12] Kangari, P., Zarnoosheh, F.T., Golchin, A., et al. (2018) Enzymatic Antioxidant and Lipid Peroxidation Evaluation in the Newly Diagnosed Breast Cancer Patients in Iran. Asian Pacific Journal of Cancer Prevention, 19, 3511-3515. [Google Scholar] [CrossRef
[13] Acevedo-León, D., Monzó-Beltrán, L., Pérez-Sánchez, L., et al. (2022) Oxidative Stress and DNA Damage Markers in Colorectal Cancer. International Journal of Molecular Sciences, 23, Article ID: 11664. [Google Scholar] [CrossRef] [PubMed]
[14] Sorolla, M.A., Hidalgo, I., Sorolla, A., et al. (2021) Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities. Cancers (Basel), 13, 5037. [Google Scholar] [CrossRef] [PubMed]
[15] Liou, G.Y. and Storz, P. (2010) Reactive Oxygen Species in Cancer. Free Radical Research, 44, 479-496. [Google Scholar] [CrossRef] [PubMed]
[16] Bossis, G., Sarry, J.E., Kifagi, C., et al. (2014) The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic Drugs. Cell Reports, 7, 1815-1823. [Google Scholar] [CrossRef] [PubMed]
[17] Kamiński, K., Kazimierczak, U. and Kolenda, T. (2022) Oxidative Stress in Melanogenesis and Melanoma Development. Współczesna Onkologia, 26, 1-7. [Google Scholar] [CrossRef] [PubMed]
[18] 王莉娟, 张国霞, 刘海龙, 等. 姜黄素抗肿瘤作用及其作用机制研究进展[J]. 甘肃中医药大学学报, 2022, 39(5): 78-82. [Google Scholar] [CrossRef
[19] 宁灿健, 余四旺. 基于核因子E2相关因子2/抗氧化反应元件信号通路探讨白黎芦醇对胃癌的化学预防作用及机制研究[J]. 中国临床药理学杂志, 2019, 35(21): 2682-2686. [Google Scholar] [CrossRef
[20] Qin, S. and Chock, P.B. (2003) Implica-tion of Phosphatidylinositol 3-Kinase Membrane Recruitment in Hydrogen Peroxide-Induced Activation of PI3K and Akt. Biochemistry, 42, 2995-3003. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, F., Zhang, X., Li, Y., et al. (2021) The Chinese Society of Clinical Oncology (CSCO): Clinical Guidelines for the Diagnosis and Treatment of Gastric Cancer, 2021. Cancer Communications, 41, 747-795. [Google Scholar] [CrossRef] [PubMed]
[22] He, Y., Wang, Y., Luan, F., et al. (2021) Chinese and Global Burdens of Gastric Cancer from 1990 to 2019. Cancer Medicine, 10, 3461-3473. [Google Scholar] [CrossRef] [PubMed]
[23] 罗劲松, 何淼, 杨桄权. 胃癌的临床诊断、形成机理以及临床治疗[J]. 基因组学与应用生物学, 2021, 40(2): 936-940. [Google Scholar] [CrossRef
[24] Wang, K., Chen, Q., Shao, Y., et al. (2021) Anticancer Activities of TCM and Their Active Components against Tumor Metastasis. Biomedicine & Pharmacotherapy, 133, Article ID: 111044. [Google Scholar] [CrossRef] [PubMed]
[25] 陈其华. 胃镜活检病理在胃癌诊断中的应用价值[J]. 中国城乡企业卫生, 2022, 37(12): 152-154. [Google Scholar] [CrossRef
[26] Shen, L., Shan, Y.S., Hu, H.M., et al. (2013) Management of Gastric Cancer in Asia: Resource-Stratified Guidelines. The Lancet Oncology, 14, e535-e547. [Google Scholar] [CrossRef
[27] 郑潇豪, 解亦斌. 中国晚期胃癌的诊疗现状[J]. 癌症进展, 2019, 17(1): 13-19+48.
[28] Caliri, A.W., Tommasi, S. and Besaratinia, A. (2021) Relationships among Smoking, Oxidative Stress, Inflammation, Macromolecular Damage, and Cancer. Mutation Research. Reviews in Mutation Re-search, 787, Article ID: 108365. [Google Scholar] [CrossRef] [PubMed]
[29] Dharshini, L.C.P., Rasmi, R.R., Kathirvelan, C., et al. (2022) Regulatory Components of Oxidative Stress and Inflammation and Their Complex Interplay in Carcinogenesis. Applied Biochemistry and Biotechnology. [Google Scholar] [CrossRef] [PubMed]
[30] 熊珊珊, 石英英, 石汉平. 活性氧与肿瘤研究进展[J]. 中华肿瘤防治杂志, 2014, 21(13): 1045-1048. [Google Scholar] [CrossRef
[31] Zang, Y.Q., Feng, Y.Y., Luo, Y.H., et al. (2019) Glycitein Induces Reactive Oxygen Species-Dependent Apoptosis and G0/G1 Cell Cycle Arrest through the MAPK/STAT3/NF-κB Pathway in Human Gastric Cancer Cells. Drug Development Research, 80, 573-584. [Google Scholar] [CrossRef] [PubMed]
[32] 艾亚楠, 赵唯含. NF-κB信号通路在胃癌前病变中的发病机制及中西医治疗的研究进展[J]. 中国实验方剂学杂志, 2022, 28(24): 237-243. [Google Scholar] [CrossRef
[33] Yang, J., Liu, Z., Zeng, B., et al. (2020) Epstein-Barr Vi-rus-Associated Gastric Cancer: A Distinct Subtype. Cancer Letters, 495, 191-199. [Google Scholar] [CrossRef] [PubMed]
[34] 张岩. EBV相关胃癌中NF-κB经典信号通路持续激活的机制研究[D]: [博士学位论文]. 青岛: 青岛大学, 2019.[CrossRef
[35] Xiang, T., Lin, Y.X., Ma, W., et al. (2018) Vasculogenic Mimicry Formation in EBV-Associated Epithelial Malignancies. Nature Communications, 9, 5009. [Google Scholar] [CrossRef] [PubMed]
[36] 郑春雷, 张忠泰, 高红. 胃癌组织中生存素和基质金属蛋白酶-9的表达及其与胃癌临床病理特点的关系[J]. 中华实验外科杂志, 2017, 34(2): 214-216.
[37] Iizasa, H., Kartika, A.V., Fekadu, S., et al. (2022) Development of Epstein-Barr Virus-Associated Gastric Cancer: Infection, Inflammation, and Oncogenesis. World Journal of Gastroenterology, 28, 6249-6257. [Google Scholar] [CrossRef] [PubMed]
[38] Wang, Y., Shang, W., Xiong, J., et al. (2021) Activable Nanopar-ticle for Tumor Aggressiveness and Drug Resistance Prediction by Glutathione Heterogeneous Imaging. Journal of Biomedical Nanotechnology, 17, 1339-1348. [Google Scholar] [CrossRef] [PubMed]
[39] Lee, Y.M., Kim, M.J., Kim, Y., et al. (2015) Glutamine Deprivation Causes Hydrogen Peroxide-Induced Interleukin-8 Expression via Jak1/Stat3 Activation in Gastric Epithelial AGS Cells. Journal of Cancer Prevention, 20, 179-184. [Google Scholar] [CrossRef
[40] Kang, H. and Kim, H. (2017) Astaxanthin and β-Carotene in Helicobacter pylori-Induced Gastric Inflammation: A Mini-Review on Action Mechanisms. Journal of Cancer Pre-vention, 22, 57-61. [Google Scholar] [CrossRef
[41] Chen, Q.H., Wu, B.K., Pan, D., Sang, L.X. and Chang, B. (2021) Beta-Carotene and Its Protective Effect on Gastric Cancer. World Journal of Clinical Cases, 9, 6591-6607. [Google Scholar] [CrossRef] [PubMed]
[42] Zardast, M., Namakin, K., Esmaelian Kaho, J. and Hashemi, S.S. (2016) Assessment of Antibacterial Effect of Garlic in Patients Infected with Helicobacter pylori Using Urease Breath Test. Avicenna Journal of Phytomedicine, 6, 495-501.
[43] Zhou, X.Y., Liu, X.Y., Li, Z. and Guo, X.H. (2022) Re-search Progress on Antitumor Effect and Molecular Mechanism of Capsaicin. China Journal of Chinese Materia Medica, 47, 4277-4283.
[44] Jones, N.L., Shabib, S. and Sherman, P.M. (1997) Capsaicin as an Inhibitor of the Growth of the Gastric Pathogen Helicobacter pylori. FEMS Microbiology Letters, 146, 223-227. [Google Scholar] [CrossRef] [PubMed]
[45] Fu, Z., Lin, L., Liu, S., Qin, M., He, S., Zhu, L. and Huang, J. (2019) Ginkgo Biloba Extract Inhibits Metastasis and ERK/Nuclear Factor kappa B (NF-κB) Signaling Pathway in Gastric Cancer. Medical Science Monitor, 25, 6836-6845. [Google Scholar] [CrossRef
[46] Gao, H., Li, H., Liu, W., Mishra, S.K. and Li, C. (2021) Andrographolide Induces Apoptosis in Gastric Cancer Cells through Reactivation of p53 and Inhibition of Mdm-2. Doklady Biochemistry and Biophysics, 500, 393-401. [Google Scholar] [CrossRef
[47] Hu, Q., Li, L., Zou, X., Xu, L. and Yi, P. (2018) Berberine At-tenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma. Frontiers in Pharmacology, 9, 1150. [Google Scholar] [CrossRef] [PubMed]
[48] Zhang, Q., Wang, X., Cao, S., et al. (2020) Berberine Represses Human Gastric Cancer Cell Growth in Vitro and in Vivo by Inducing Cytostatic Autophagy via Inhibition of MAPK/mTOR/p70S6K and Akt Signaling Pathways. Biomedicine & Pharmacotherapy, 128, Article ID: 110245. [Google Scholar] [CrossRef] [PubMed]
[49] Bahrami, A. and Ferns, G. (2021) Effect of Curcumin and Its Derivates on Gastric Cancer: Molecular Mechanisms. Nutrition and Cancer, 73, 1553-1569. [Google Scholar] [CrossRef] [PubMed]
[50] Sun, C., Zhang, S., Liu, C. and Liu, X. (2019) Curcumin Promoted miR-34a Expression and Suppressed Proliferation of Gastric Cancer Cells. Cancer Biotherapy and Radio-pharmaceuticals, 34, 634-641. [Google Scholar] [CrossRef] [PubMed]
[51] Lyu, Z.K., Li, C.L., Jin, Y., et al. (2017) Paeonol Exerts Potential Ac-tivities to Inhibit the Growth, Migration and Invasion of Human Gastric Cancer BGC823 Cells via Downregulating MMP-2 and MMP-9. Molecular Medicine Reports, 16, 7513-7519. [Google Scholar] [CrossRef] [PubMed]